Pharmacoeconomics of Occupational Diseases

  • Matthias AugustinEmail author
Reference work entry


Due to its increasing frequency and the wide-ranging consequences for the affected patients, occupational skin diseases are of great socioeconomic importance. In light of this, clinical and epidemiological research is devoted increasingly to the effect of the disease on quality of life and to costs. In all studies published to date, there is a marked economic relevance of occupational skin diseases. Depending on the severity and the impact on work, the annual costs are in the same range or even exceed those for chronic inflammatory skin disease like psoriasis and atopic eczema. Moreover, significant limitations of quality of life are reported for patients with occupational skin diseases. The stress for these patients in many studies exceeds that of other skin diseases and also for chronic diseases.


Direct costs Health-related quality of life (HRQoL) Indirect costs Intangible costs Patient-reported outcomes (PRO) Pharmacoeconomics 


  1. Anderson RT, Rajagopalan R (1997) Development and validation of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol 37(1):41–50PubMedCrossRefGoogle Scholar
  2. Apfelbacher CJ, Radulescu M, Diepgen TL, Funke U (2008) Occurrence and prognosis of hand eczema in the car industry: results from the PACO follow-up study. Contact Dermatitis 58:322–329PubMedCrossRefGoogle Scholar
  3. Apfelbacher CJ, Soder S, Diepgen TL, Weisshaar E (2009) The impact of measures for secondary individual prevention of work-related skin diseases in health care workers: 1-year follow-up study. Contact Dermatitis 60(3):144–149PubMedCrossRefGoogle Scholar
  4. Augustin M, Amon U, Braathen L, Bullinger M, Gieler U, Klein GF, Schultz-Amling W (2004) Erfassung von Lebensqualität in der Dermatologie (Leitlinie). J Dtsch Dermatol Ges 9:802–806Google Scholar
  5. Augustin M, Radtke MA, Zschocke I, Blome C, Behechtnejad J, Schäfer I, Reusch M, Mielke V, Rustenbach SJ (2009) The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases. Arch Dermatol Res 301(8): 561–571PubMedCrossRefGoogle Scholar
  6. Augustin M, Kuessner D, Purwins S, Hieke K, Posthumus J, Diepgen TL (2011) Cost-of-illness of patients with chronic hand eczema in routine care: results from a multi-centre study in Germany. Br J Dermatol 165(4):845–851PubMedCrossRefGoogle Scholar
  7. Blanciforti LA (2010) Economic burden of dermatitis in US workers (corrected). J Occup Environ Med 52(11): 1045–1054PubMedCrossRefGoogle Scholar
  8. Blank PR, Blank AA, Szucs TD (2010) Cost-effectiveness of oral alitretinoin in patients with severe chronic hand eczema – a long- term analysis from a Swiss perspective. BMC Dermatol 10:4PubMedPubMedCentralCrossRefGoogle Scholar
  9. Blome C, Maares J, Diepgen T, Rustenbach SJ, Augustin M (2009) Measurement of patient-relevant benefits in the treatment of chronic hand eczema – a novel approach. Contact Dermatitis 61:39–45PubMedCrossRefGoogle Scholar
  10. Brock D (1996) Quality of life measures in health care and medical ethics. In: Spilker B (ed) Quality of life and pharmacoeconomics in clinical trials, 2nd edn. Lippincott-Raven, Philadelphia, pp 487–510. (Revised)Google Scholar
  11. Bullinger M, Anderson R, Cella D, Aaronson N (1993) Developing and evaluating cross-cultural instruments from minimum requirements to optimal models. Qual Life Res 2(6):451–459PubMedCrossRefGoogle Scholar
  12. Cherry N, Meyer JD, Adisesh A, Brooke R, Owen-Smith V, Swales C, Beck MH (2000) Surveillance of occupational skin disease: EPIDERM and OPRA. Br J Dermatol 142:1128–1134PubMedCrossRefGoogle Scholar
  13. Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ (1996) Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 107(5):707–713PubMedCrossRefGoogle Scholar
  14. Coenraads PJ, Diepgen TL (1998) Risk for hand eczema in employees with past or present atopic dermatitis. Int Arch Occup Environ Health 71:7–13PubMedCrossRefGoogle Scholar
  15. Cvetkovski RS, Zachariae R, Jensen H, Olsen J, Johansen JD, Agner T (2006) Quality of life and depression in a population of occupational hand eczema patients. Contact Dermatitis 54(2):106–111PubMedCrossRefGoogle Scholar
  16. Dickel H, Kuss O, Blesius CR, Schmidt A, Diepgen TL (2001) Occupational skin diseases in Northern Bavaria between 1990 and 1999: a population based study. Br J Dermatol 145:453–462PubMedCrossRefGoogle Scholar
  17. Dickel H, Kuss O, Schmidt A, Diepgen TL (2002) Impact of preventive strategies on trend of occupational skin disease in hairdressers: population-based register study. Br Med J 324:1422–1423CrossRefGoogle Scholar
  18. Dickel H, Bruckner TM, Schmidt A, Diepgen TL (2003) Impact of atopic skin diathesis on occupational skin disease incidence in a working population. J Invest Dermatol 121:37–40PubMedCrossRefGoogle Scholar
  19. Diepgen TL, Purwins S, Posthumus J, Kuessner D, John SM, Augustin M (2013a) Cost-of-illness analysis of patients with chronic hand eczema in routine care in Germany: focus on the impact of occupational disease. Acta Derm Venereol 93:538–543PubMedCrossRefGoogle Scholar
  20. Diepgen TL, Scheidt R, Weisshaar E, John SM, Hieke K (2013b) Cost of illness from occupational hand eczema in Germany. Contact Dermatitis 69:99–106PubMedCrossRefGoogle Scholar
  21. Drake L, Prendergast M, Maher R, Breneman D, Korman N, Satoi Y, Beusterien KM, Lawrence I (2001) The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. J Am Acad Dermatol 44:S65–S72PubMedCrossRefGoogle Scholar
  22. Drummond M, McGuire A (2001) Economic evaluation in health care. Oxford University Press, OxfordGoogle Scholar
  23. Dulon M, Pohrt U, Skudlik C, Nienhaus A (2009) Prevention of occupational skin disease: a workplace intervention study in geriatric nurses. Br J Dermatol 161:337–344PubMedCrossRefGoogle Scholar
  24. Flyvholm MA, Mygind K, Sell L, Jensen A, Jepsen KF (2005) A randomised controlled intervention study on prevention of work related skin problems among gut cleaners in swine slaughterhouses. Occup Environ Med 62:642–649PubMedPubMedCentralCrossRefGoogle Scholar
  25. Granlund H, Erkko P, Remitz A, Langeland T, Helsing P, Nuutinen M, Reitamo S (2001) Comparison of cyclosporin and UVAB phototherapy for intermittent one-year treatment of atopic dermatitis. Acta Derm Venereol 81:22–27PubMedCrossRefGoogle Scholar
  26. Harper JI, Ahmed I, Barclay G, Lacour M, Hoeger P, Cork MJ, Finlay AY, Wilson NJ, Graham-Brown RA, Sowden JM, Beard AL, Sumner MJ, Berth-Jones J (2000) Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol 142:52–58PubMedCrossRefGoogle Scholar
  27. Held E, Mygind K, Wolff C, Gyntelberg F, Agner T (2002) Prevention of work related skin problems: an intervention study in wet work employees. Occup Environ Med 59:556–561PubMedPubMedCentralCrossRefGoogle Scholar
  28. Holness DL, Nethercott JR (1995) Work outcome in workers with occupational skin disease. Am J Ind Med 27:807–815PubMedCrossRefGoogle Scholar
  29. Hutchings CV, Shum KW, Gawkrodger DJ (2001) Occupational contact dermatitis has an appreciable impact on quality of life. Contact Dermatitis 45(1):17–20PubMedCrossRefGoogle Scholar
  30. Kubota K, Machida I, Tamura K, Take H, Kurabayashi H, Akiba T, Tamura J (1997) Treatment of refractory cases of atopic dermatitis with acidic hot- spring bathing. Acta Derm Venereol 77:452–454PubMedGoogle Scholar
  31. Kütting B, Baumeister T, Weistenhöfer W, Pfahlberg A, Uter W, Drexler H (2010) Effectiveness of skin protection measures in prevention of occupational hand eczema: results of a prospective randomized controlled trial over a follow-up period of 1 year. Br J Dermatol 162:362–370PubMedCrossRefGoogle Scholar
  32. Lange S, Zschocke I, Langhardt S, Amon U, Augustin M (1999) Effects of combined dermatological and behavioural medicine therapy in hospitalized patients with psoriasis and atopic dermatitis. Hautarzt 50: 791–797PubMedCrossRefGoogle Scholar
  33. Lau MY, Burgess JA, Nixon R, Dharmage SC, Matheson MC (2011a) A review of the impact of occupational contact dermatitis on quality of life. J Allergy (Cairo) 2011:964509Google Scholar
  34. Lau MY, Matheson MC, Burgess JA, Dharmage SC, Nixon R (2011b) Disease severity and quality of life in a follow-up study of patients with occupational contact dermatitis. Contact Dermatitis 65(3):138–145PubMedCrossRefGoogle Scholar
  35. Mälkönen T, Jolanki R, Alanko K, Luukonen R, Aalto-Korte K, Lauerma A, Susitaival P (2009) A 6-month follow-up study of 1048 patients diagnosed with an occupational skin disease. Contact Dermatitis 61:261–268PubMedCrossRefGoogle Scholar
  36. Mälkönen T, Alanko K, Jolanki R, Luukkonen R, Aalto-Korte K, Lauerma A, Susitaival P (2010) Long-term follow-up study of occupational hand eczema. Br J Dermatol 163:999–1006PubMedCrossRefGoogle Scholar
  37. Matterne U, Apfelbacher CJ, Soder S, Diepgen TL, Weisshaar E (2009) Health-related quality of life in health care workers with work-related skin diseases. Contact Dermatitis 61(3):145–151PubMedCrossRefGoogle Scholar
  38. McCall BP, Horwitz IB, Feldman SR, Balkrishnan R (2005) Incidence rates, costs, severity, and work-related factors of occupational dermatitis: a workers’ compensation analysis of Oregon, 1990–1997. Arch Dermatol 141(6):713–718PubMedCrossRefGoogle Scholar
  39. McDonald JC, Beck MH, Chen Y, Cherry NM (2006) Incidence by occupation and industry of work-related skin diseases in the United Kingdom 1996–2001. Occup Med 56:398–405CrossRefGoogle Scholar
  40. Mohla G, Horvath N, Stevens S (1999) Quality of life improvement in a patient with severe atopic dermatitis treated with photopheresis. J Am Acad Dermatol 40:780–782PubMedCrossRefGoogle Scholar
  41. Morgan M, McCreedy R, Simpson J, Hay RJ (1997) Dermatology quality of life scales – a measure of the impact of skin diseases. Br J Dermatol 136(2):202–206PubMedCrossRefGoogle Scholar
  42. Nienhaus A, Kromark K, Raulf-Heimsoth M, van Kampen V, Merget R (2008) Outcome of occupational latex allergy – work ability and quality of life. PLoS One 3(10):e3459PubMedPubMedCentralCrossRefGoogle Scholar
  43. Nilsson GE, Mikaelsson B, Andersson S (1985) Atopy, occupation and domestic work as risk factors for hand eczema in hospital workers. Contact Dermatitis 13:216–223PubMedCrossRefGoogle Scholar
  44. Paulden M, Rodgers M, Griffin S, Slack R, Duffy S, Ingram JR, Woolacott N, Sculpher M (2010) Alitretinoin for the treatment of severe chronic hand eczema. Health Technol Assess 14(Suppl 1):39–46PubMedCrossRefGoogle Scholar
  45. Rabin B, Fraidlin N (2007) Patients with occupational contact dermatitis in Israel: quality of life and social implications. Soc Work Health Care 45(2):97–111PubMedCrossRefGoogle Scholar
  46. Rodgers M, Griffin S, Paulden M, Slack R, Duffy S, Ingram JR, Woolacott N, Sculpher M (2010) Alitretinoin for severe chronic hand eczema: a NICE single technology appraisal. Pharmacoeconomics 28(5):351–362PubMedCrossRefGoogle Scholar
  47. Salek MS, Finlay AY, Luscombe DK, Allen BR, Berth-Jones J, Camp RD, Graham-Brown RA, Khan GK, Marks R, Motley RJ (1993) Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial. Br J Dermatol 129:422–430PubMedCrossRefGoogle Scholar
  48. Schipper H, Clinch JJ, Olweny CHLM (1996) Quality of life studies: definition and conceptual issues. In: Spilker B (ed) Quality of life and pharmacoeconomics in clinical trials. Lippincott-Raven, Philadelphia, pp 11–24Google Scholar
  49. Soder S, Diepgen TL, Radulescu M, Apfelbacher CJ, Bruckner T, Weisshaar E (2007) Occupational skin diseases in cleaning and kitchen employees: course and quality of life after measures of secondary individual prevention. J Dtsch Dermatol Ges 5(8):670–676PubMedCrossRefGoogle Scholar
  50. Spilker B (ed) (1996) Quality of life and pharmacoeconomics in clinical trials. Lippincott-Raven, Philadelphia, pp 11–24Google Scholar
  51. Thyssen JP, Johansen JD, Linneberg A, Menné T (2010) The epidemiology of hand eczema in the general population – prevalence and main findings. Contact Dermatitis 62(2):75–87PubMedCrossRefGoogle Scholar
  52. Turner S, Carder N, van Tongeren M, McNamee R, Lines S, Hussey L, Bolton A, Beck MH, Wilkinson M, Agius R (2007) The incidence of occupational skin disease as reported to The Health and Occupation Reporting (THOR) network between 2002 and 2005. Br J Dermatol 157:713–722PubMedCrossRefGoogle Scholar
  53. van Gils RF, Boot CR, van Gils PF, Bruynzeel D, Coenraads PJ, van Mechelen W, Riphagen II, Anema JR (2011) Effectiveness of prevention programmes for hand dermatitis: a systematic review of the literature. Contact Dermatitis 64(2):63–72PubMedCrossRefGoogle Scholar
  54. Winker R, Salameh B, Stolkovich S, Nikl M, Barth A, Ponocny E, Drexler H, Tappeiner G (2009) Effectiveness of skin protection creams in the prevention of occupational dermatitis: results of a randomized, controlled trial. Int Arch Occup Environ Health 82:653–662PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Institute for Health Services Research in Dermatology and Nursing (IVDP)University Medical Center Hamburg-Eppendorf (UKE)HamburgGermany

Personalised recommendations